News
The FDA said the biosimilar, called Tyruko, has been approved to treat adults with relapsing forms of MS and active secondary progressive MS, as well as for certain patients with Crohn's disease ...
Sanofi has bolstered the case for its oral BTK inhibitor tolebrutinib as a treatment for multiple sclerosis (MS), due to be filed for approval in the latter half of this year, with new data in a ...
Another is taking advantage of how defenses have evolved. And the new kickoff rules have affected much more than just special teams. Patrick Mahomes, Matthew Stafford offer similar reasons for not ...
First of all, the Premier League will have five teams in the UCL next season after it secured one of the extra places for performance by clubs across the three competitions. But what happened with ...
So the bottom line is that with four teams within a point of them, Newcastle can only contemplate a win being enough on the final day to book a place in the Champions League. Because their goal ...
Look back at the winners of every NBA award, All-NBA team and more in NBA history. Take a look back at every Kia NBA MVP award winner in league history. Check out every All-Rookie honoree since ...
Ocrevus (ocrelizumab) is a prescription drug that’s used to treat certain relapsing forms of multiple sclerosis (MS) and primary progressive MS. Keep reading to learn about the common ...
There's still plenty of time for teams that have been good so far to fall apart and also tons of time for a disappointing team to get hot and do something like win 15 of 20 to thrust themselves ...
The postseason field has now been whittled from 20 teams down to three. The Kings, Mavericks, Bulls and Hawks were ousted in the Play-In Tournament. The Grizzlies, Clippers, Lakers, Rockets ...
The playoffs are seeded based on the teams' league finishes this season. That means the team that places third in the final league standings faced the team in sixth, while fourth place took on fifth.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results